28 related articles for article (PubMed ID: 30868841)
1. miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia.
Hadi N; Namazi F; Ketabchi F; Khosravian F; Nateghi B; Talebi A; Baghi M; Mianesaz H; Zare F; Salehi M
Pathol Res Pract; 2022 Oct; 238():154077. PubMed ID: 36037658
[TBL] [Abstract][Full Text] [Related]
2. Regulatory role of miR-125a expression with respect to its target genes LIFR, ERBB2 and STAT3 in the pathogenesis of recurrent pregnancy losses.
Manzoor U; Pandith AA; Amin I; Wani S; Baba SM; Wani UM; Mansoor S; Aein QU; Anwar I; Bahar B; Koul AM; Sanadhya D; Ahmad A
Int J Gynaecol Obstet; 2024 Mar; ():. PubMed ID: 38528801
[TBL] [Abstract][Full Text] [Related]
3. An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects.
Alharthi A; Beck D; Howard DR; Hillmen P; Oates M; Pettitt A; Wagner SD
BMC Res Notes; 2018 May; 11(1):280. PubMed ID: 29739419
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
Casabonne D; Benavente Y; Seifert J; Costas L; Armesto M; Arestin M; Besson C; Hosnijeh FS; Duell EJ; Weiderpass E; Masala G; Kaaks R; Canzian F; Chirlaque MD; Perduca V; Mancini FR; Pala V; Trichopoulou A; Karakatsani A; La Vecchia C; Sánchez MJ; Tumino R; Gunter MJ; Amiano P; Panico S; Sacerdote C; Schmidt JA; Boeing H; Schulze MB; Barricarte A; Riboli E; Olsen A; Tjønneland A; Vermeulen R; Nieters A; Lawrie CH; de Sanjosé S
Int J Cancer; 2020 Sep; 147(5):1315-1324. PubMed ID: 32012253
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia.
Hussein S; Abdelazem AS; Abdelmoneem S; Abdelnabi AM; Khamis T; Obaya AA; Ebian HF
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2735-2742. PubMed ID: 36037128
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case-control study.
Davari N; Ahmadpour F; Kiani AA; Azadpour M; Asadi ZT
BMC Res Notes; 2021 Jan; 14(1):21. PubMed ID: 33430952
[TBL] [Abstract][Full Text] [Related]
7. microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V
Front Immunol; 2020; 11():1214. PubMed ID: 32793185
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis.
Javandoost E; Firoozi-Majd E; Rostamian H; Khakpoor-Koosheh M; Mirzaei HR
Curr Med Chem; 2020; 27(2):282-297. PubMed ID: 31544709
[TBL] [Abstract][Full Text] [Related]
10. Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia.
Ahmadvand M; Eskandari M; Khakpour G; Pashaiefar H; Manoochehrabadi S; Yaghmaie M; Montazer-Zohour M; Naghavi A
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868841
[No Abstract] [Full Text] [Related]
11. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
Fathullahzadeh S; Mirzaei H; Honardoost MA; Sahebkar A; Salehi M
Cancer Gene Ther; 2016 Oct; 23(10):327-332. PubMed ID: 27659777
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
[TBL] [Abstract][Full Text] [Related]
14. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.
Li Z; Jiang J; Tian L; Li X; Chen J; Li S; Li C; Yang Z
PLoS One; 2017; 12(5):e0175407. PubMed ID: 28467514
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
